This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


NanoViricides, Inc.

Drug Names(s): FluCide-I, NV-INF-1

Description: NV-INF-1 is an anti-influenza clinical drug candidate designed from nanoviricide technology.

A nanoviricide is designed to specifically seek and attach to a virus particle, engulfing the virus particle in the process, thereby theoretically rendering it incapable of infecting new cells.

FluCide News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug